813
Views
13
CrossRef citations to date
0
Altmetric
Position paper

Best practice in placement of percutaneous endoscopic gastrostomy with jejunal extension tube for continuous infusion of levodopa carbidopa intestinal gel in the treatment of selected patients with Parkinson’s disease in the Nordic region

, , , , , , , , , & show all
Pages 1500-1507 | Received 29 Dec 2014, Accepted 23 May 2015, Published online: 19 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sara Cococcia, Laura Rovedatti, Marco Vincenzo Lenti, Lodovica Pozzi, Federico De Grazia & Antonio Di Sabatino. (2020) Safety and durability of PEG-J: a single-centre experience. Scandinavian Journal of Gastroenterology 55:11, pages 1377-1380.
Read now
Yuji Ishibashi, Yasushi Shimo, Yukinori Yube, Shinichi Oka, Hiroki Egawa, Yoshinori Kohira, Sanae Kaji, Satoshi Kanda, Genko Oyama, Taku Hatano, Nobutaka Hattori & Tetsu Fukunaga. (2019) Technique and outcome of percutaneous endoscopic transgastric jejunostomy for continuous infusion of levodopa-carbidopa intestinal gel for treatment of Parkinson’s disease. Scandinavian Journal of Gastroenterology 54:6, pages 787-792.
Read now

Articles from other publishers (11)

K. E. Grund, A. Zipfel, B. Duckworth-Mothes & W. H. Jost. (2023) Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome. Journal of Neural Transmission 130:11, pages 1383-1394.
Crossref
Simone Simoni, Pasquale Nigro, Marta Filidei, Giulia Cappelletti, Federico Paolini Paoletti, Danilo Castellani, Mirko Gaggiotti, Lucilla Parnetti & Nicola Tambasco. (2022) PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study. BMC Neurology 22:1.
Crossref
Alessandro Fugazza, Antonio Capogreco, Annalisa Cappello, Rosangela Nicoletti, Leonardo Da Rio, Piera Alessia Galtieri, Roberta Maselli, Silvia Carrara, Gaia Pellegatta, Marco Spadaccini, Edoardo Vespa, Matteo Colombo, Kareem Khalaf, Alessandro Repici & Andrea Anderloni. (2022) Percutaneous endoscopic gastrostomy and jejunostomy: Indications and techniques. World Journal of Gastrointestinal Endoscopy 14:5, pages 250-266.
Crossref
A.-S. Blaise, G. Baille, N. Carrière, D. Devos, K. Dujardin, G. Grolez, A. Kreisler, M. Kyheng, C. Moreau, E. Mutez, D. Seguy & L. Defebvre. (2020) Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study. Revue Neurologique 176:4, pages 268-276.
Crossref
Carmen Garrido Durán, Sam Khorrami Minaei, Pau Sendra Rumbeu, Joaquín Fernández García, Marcelo García Hernández & Inés Legarda Ramírez. (2019) Endoscopic management of duodenal levodopa-carbidopa therapy of advanced Parkinson�s disease. Revista Española de Enfermedades Digestivas 111.
Crossref
Nirosen Vijiaratnam & Carolyn M. Sue. (2018) Maximizing benefits of the levodopa/carbidopa intestinal gel: Systematic considerations, challenging convention and individualizing approaches. Basal Ganglia 14, pages 58-60.
Crossref
. (2018) UEG Week 2018 Poster Presentations. United European Gastroenterology Journal 6:S8.
Crossref
Nirosen Vijiaratnam & Carolyn M. Sue. (2018) Levodopa-carbidopa intestinal gel: ‘dismantling the road blocks of a journey’. Internal Medicine Journal 48:4, pages 472-474.
Crossref
Johan Virhammar & Dag Nyholm. (2016) Levodopa-carbidopa enteral suspension in advanced Parkinson’s disease: clinical evidence and experience. Therapeutic Advances in Neurological Disorders 10:3, pages 171-187.
Crossref
Julian Cheron, Jacques Deviere, Frederic Supiot, Asuncion Ballarin, Pierre Eisendrath, Emmanuel Toussaint, Vincent Huberty, Carmen Musala, Daniel Blero, Arnaud Lemmers, André Van Gossum & Marianna Arvanitakis. (2017) The use of enteral access for continuous delivery of levodopa‐carbidopa in patients with advanced Parkinson’s disease. United European Gastroenterology Journal 5:1, pages 60-68.
Crossref
Marina Senek, Elisabet I. Nielsen & Dag Nyholm. (2017) Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study. Movement Disorders 32:2, pages 283-286.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.